Immunological and Molecular Biological Study on Oncogenes In Human Oral Cancer.
Immunological and Molecular Biological Study on Oncogenes In Human Oral Cancer.
批准号:
63570929
负责人:
SHIOIRI Shigeaki
金额:
$1.47万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1988
资助国家:
日本
项目状态:
已结题
起止时间:
1988 至 1989
中文摘要
1)应用抗p21单克隆抗体免疫组织化学方法,对口腔癌组织中rasp 21的表达进行了研究。恶性肿瘤和良性肿瘤均呈阳性染色,且染色强度具有相对性。因此,似乎无法评价临床恶性程度。(2)EJ c-H-ras-1的2.9kb Sac I片段,有4个编码外显子,但没有5'端启动子区和3'端的VTR,与肿瘤病毒的启动子/增强子或3 '端的增强子区反向连接。将pUC 18质粒中的这些构建体转染到NIH 3 T3细胞上,发现其诱导病灶的效率约为其中启动子/增强子片段以相同方向连接到片段的相应构建体的效率的10%,而单独的截短的c-H-ras-1的转化效率小于1%。结果表明,病毒增强子增加截短的c-H-ras-1的转化活性。为了进一步研究这种增强作用,将上游缺失引入到与Moloney LTR反向连接的截短的e-H-ras-1中,并将缺失质粒转染到NIH 3 T3细胞中。从SacI上游位点(-615)到起始密码子-150左右的缺失没有显著降低转化活性,而从-150到-50的缺失突变体的转化活性很低,这表明控制元件可能位于该区域内。在3 Y1细胞中,我们还通过与连接到MoMSV LTR的c-myc共转染来检测截短的c-H-ras-1的转化活性。诱导灶的数量增加了几倍,表明c-myc增强了截短的c-H-ras-1的转化活性。
英文摘要
1) The ras p21 expression in human oral carcinoma tissue specimens was studied by immunohistochemistry with monoclonal antibodies against p2l. Not only malignant tumors, but also benigns were stained positively, and the staining intensities were relative. Therefore, it seemed to be impossible to evaluate the clinical malignancy. In addition, the expressions of Rb gene mRNA was investigated in seven human oral carcinoma cell lines and found to be normal in all of the cell lines.2) The 2.9kb Sac I fragment of EJ c-H-ras-1 with 4 coding exons but without its own 5' promoter region and the VTR at 3' side was linked to tumor viruses's promoter/enhancer or only enhancer region at the 3' end in the opposite direction. These constructions in pUC18 plasmid were transfected onto NIH3T3 cells and found to induce foci with efficiencies of about 10% of those of the corresponding constructs in which the promoter/enhancer fragments were linked to the fragment in the same direction, while the transforming efficiency of the truncated c-H-ras-1 alone was less than 1%. The results suggests that viral enhancers increase transforming activity of the truncated c-H-ras-1. To further study the enhancement, upstream deletions were introduced into the truncated e-H-ras-1 linked to Moloney LTR in the opposite direction, and deletion plasmids were transfected onto NIH3T3 cells. Deletions from the upstream SacI site (-615) to around -150 from the initiation codon did not significantly lower the transforming activities, while the transforming activities of deletion mutants from -15O to -50 were low, suggesting that the controlling element may reside within this region. We examined also transforming activity of the truncated c-H-ras-1 by cotransfecting with c-myc linked to MoMSV LTR, in 3Y1 cells. The number of induced foci increased several fold, suggesting that c-myc enhances transforming activity of the truncated c-H-ras-1.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Koyama,T: "Enhancement of transforming activities of truncated EJ c-H-ras-1 with viral enhancers or with myc" ABSTRACT BOOK THE MOLECULAR BASIS OF CELL GROWTH REGULATION. B6 (1989)
Koyama,T:“用病毒增强剂或 myc 增强截短的 EJ c-H-ras-1 的转化活性”摘要书《细胞生长调节的分子基础》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Koyama,T.: "Enhancement of transforming activities of trunated EJ c-H-ras-I with viral enhancers of with myc" ABSTRACT BOOK THE MOLECULAR BASIS OF CELL GROWTH REGULATION. B6 (1989)
Koyama,T.:“用 myc 的病毒增强剂增强截短的 EJ c-H-ras-I 的转化活性”摘要书《细胞生长调节的分子基础》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T. koyama: "Enhancement of transforming activities of truncated EJ c-H-ras-1 with viral enhancers or with myc." ABSTRACT BOOK THE MOLECULAR BASIS OF CELL GROWTH REGULATION B6, 1989.
T. koyama:“用病毒增强剂或 myc 增强截短的 EJ c-H-ras-1 的转化活性。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Study for enhancement of VEGF production and angiogenesis in human Human oral squamous cell carcinoma cell
-
批准号:12671926
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2000
-
负责人:SHIOIRI Shigeaki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
软饮食下Igfbp5调控p53/p21通路诱导颞下颌关节退行性变的机制研究
-
批准号:2026JJ60602
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周典
-
依托单位:
LincRNA-p21通过p21及p53通路调控细胞增殖与凋亡参与PAH肺血管重构的分子机制研究
-
批准号:2025A01015
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李泽荣
-
依托单位:
基于卵巢衰老图谱探究NLRP3⁺巨噬细胞经由WT1/p21轴抑制颗粒细胞功能的机制研究
-
批准号:82501955
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:李仲康
-
依托单位:
戊酸调控TBX3/p21通路抑制肝细胞衰老缓解酒精性肝损伤的机制研究
-
批准号:82500743
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:徐琦
-
依托单位:
APEX1调控p53/p21信号通路通过缓解软骨细胞衰老延缓创伤性骨关节炎的机制研究
-
批准号:2025JJ80999
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:何春荣
-
依托单位:
通过Sp1/HDAC1/p21途径探索结直肠癌细胞增殖的机制研究
-
批准号:2025JJ70237
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:姜小叶
-
依托单位:
基于骨髓造血干细胞DNA损伤诱导p53调控p21/RB衰老和Bcl-2/caspase-3凋亡通路探讨健脾补肾方抗辐射的机制
-
批准号:82574833
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2025
-
负责人:何东初
-
依托单位:
玄参活性成分哈巴俄苷通过Sirt5介导的p21启动子去琥珀酰化促进缺血再灌注损伤后心肌细胞再生的作用及机制研究
-
批准号:KLY25H270043
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:黄明远
-
依托单位:
长非编码RNA P21-DIPOT在DNA损伤修复中的作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:王玉茗
-
依托单位:
DCAF13 通过泛素化降解 PAK1IP1调控
p53/p21 通路介导的细胞衰老促进肝癌进展的
机制及其作为临床标志物的价值研究
-
批准号:BY24H180080
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:许浏
-
依托单位: